Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roderick T Bronson

Showing results (251-260 of 319) with videos related to

Pageof 32
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|October 5, 2021
<i>BRCA1/Trp53</i> heterozygosity and replication stress drive esophageal cancer development in a mouse modelYe He, Joshua Rivera, Miklos Diossy, et al.
Immunity|August 23, 2003
Autoimmunity as the consequence of a spontaneous mutation in Rasgrp1Katrin Layer, Guosheng Lin, Alessio Nencioni, et al.
NPJ Breast Cancer|September 6, 2018
<i>NF1</i> deficiency correlates with estrogen receptor signaling and diminished survival in breast cancerPatrick S Dischinger, Elizabeth A Tovar, Curt J Essenburg, et al.
Cancer Cell|September 13, 2011
Exploiting cancer cell vulnerabilities to develop a combination therapy for ras-driven tumorsThomas De Raedt, Zandra Walton, Jessica L Yecies, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 27, 2018
BRCA1-IRIS promotes human tumor progression through PTEN blockade and HIF-1α activationAndrew G Li, Elizabeth C Murphy, Aedin C Culhane, et al.
American Journal of Human Genetics|January 16, 2002
Mutations in a novel CLN6-encoded transmembrane protein cause variant neuronal ceroid lipofuscinosis in man and mouseHanlin Gao, Rose-Mary N Boustany, Janice A Espinola, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 4, 2013
Concomitant BRAF and PI3K/mTOR blockade is required for effective treatment of BRAF(V600E) colorectal cancerErin M Coffee, Anthony C Faber, Jatin Roper, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 6, 2016
Mutational landscape of EGFR-, MYC-, and Kras-driven genetically engineered mouse models of lung adenocarcinomaDavid G McFadden, Katerina Politi, Arjun Bhutkar, et al.
Cancer Cell|February 4, 2014
UHRF1 overexpression drives DNA hypomethylation and hepatocellular carcinomaRaksha Mudbhary, Yujin Hoshida, Yelena Chernyavskaya, et al.
Nature Cell Biology|February 14, 2017
G1 cyclins link proliferation, pluripotency and differentiation of embryonic stem cellsLijun Liu, Wojciech Michowski, Hiroyuki Inuzuka, et al.
Pageof 32

Showing results (251-260 of 319) with videos related to

Sort By:
Pageof 32
Proceedings of the National Academy of Sciences of the United States of America|October 5, 2021
<i>BRCA1/Trp53</i> heterozygosity and replication stress drive esophageal cancer development in a mouse modelYe He, Joshua Rivera, Miklos Diossy, et al.
Immunity|August 23, 2003
Autoimmunity as the consequence of a spontaneous mutation in Rasgrp1Katrin Layer, Guosheng Lin, Alessio Nencioni, et al.
NPJ Breast Cancer|September 6, 2018
<i>NF1</i> deficiency correlates with estrogen receptor signaling and diminished survival in breast cancerPatrick S Dischinger, Elizabeth A Tovar, Curt J Essenburg, et al.
Cancer Cell|September 13, 2011
Exploiting cancer cell vulnerabilities to develop a combination therapy for ras-driven tumorsThomas De Raedt, Zandra Walton, Jessica L Yecies, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 27, 2018
BRCA1-IRIS promotes human tumor progression through PTEN blockade and HIF-1α activationAndrew G Li, Elizabeth C Murphy, Aedin C Culhane, et al.
American Journal of Human Genetics|January 16, 2002
Mutations in a novel CLN6-encoded transmembrane protein cause variant neuronal ceroid lipofuscinosis in man and mouseHanlin Gao, Rose-Mary N Boustany, Janice A Espinola, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 4, 2013
Concomitant BRAF and PI3K/mTOR blockade is required for effective treatment of BRAF(V600E) colorectal cancerErin M Coffee, Anthony C Faber, Jatin Roper, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 6, 2016
Mutational landscape of EGFR-, MYC-, and Kras-driven genetically engineered mouse models of lung adenocarcinomaDavid G McFadden, Katerina Politi, Arjun Bhutkar, et al.
Cancer Cell|February 4, 2014
UHRF1 overexpression drives DNA hypomethylation and hepatocellular carcinomaRaksha Mudbhary, Yujin Hoshida, Yelena Chernyavskaya, et al.
Nature Cell Biology|February 14, 2017
G1 cyclins link proliferation, pluripotency and differentiation of embryonic stem cellsLijun Liu, Wojciech Michowski, Hiroyuki Inuzuka, et al.
Pageof 32